Jack L. Erion
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Epidemiology top 2%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 21
- Neuroendocrine Tumor Research Advances 21
- Oncology 17
- Lung Cancer Research Studies 10
- Peptidase Inhibition and Analysis 6
- Co-authors
- Marion de Jong (13 shared papers)Eric P. Krenning (13 shared papers)Michelle Schmidt (12 shared papers)Willem H. Bakker (5 shared papers)Ananth Srinivasan (10 shared papers)Joan E.B. Fox (5 shared papers)Dik J. Kwekkeboom (4 shared papers)P.P.M. Kooij (4 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (9 papers)Cancer Biotherapy and Radiopharmaceuticals (3 papers)Bioconjugate Chemistry (3 papers)Nuclear Medicine Communications (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Jack L. Erion
45 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 91
- Radiology, Nuclear Medicine and Imaging 1.2k
- Epidemiology 1.3k
- Oncology 1.0k
- Neurology 518
- Cellular and Molecular Neuroscience 194
Countries citing papers authored by Jack L. Erion
This map shows the geographic impact of Jack L. Erion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Erion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Erion more than expected).
Fields of papers citing papers by Jack L. Erion
This network shows the impact of papers produced by Jack L. Erion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Erion. The network helps show where Jack L. Erion may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack L. Erion, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 401 | |
| 2 | 2003 | 340 | |
| 3 | Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. | 1998 | 192 |
| 4 | 2003 | 186 | |
| 5 | 2001 | 184 | |
| 6 | 2014 | 115 | |
| 7 | 2002 | 113 | |
| 8 | 1975 | 101 | |
| 9 | 2003 | 89 | |
| 10 | Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy. | 2002 | 79 |
| 11 | 2000 | 75 | |
| 12 | 1998 | 75 | |
| 13 | 2009 | 65 | |
| 14 | 2003 | 65 | |
| 15 | 2002 | 63 | |
| 16 | 2007 | 63 | |
| 17 | 2008 | 59 | |
| 18 | 2007 | 58 | |
| 19 | 2001 | 56 | |
| 20 | Anticancer activity of targeted proapoptotic peptides. | 2006 | 51 |
About Jack L. Erion
Jack L. Erion is a scholar working on Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Neurology, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (21 papers), Radiopharmaceutical Chemistry and Applications (13 papers), Lung Cancer Research Studies (10 papers), Neuroblastoma Research and Treatments (9 papers), Neuropeptides and Animal Physiology (7 papers), Peptidase Inhibition and Analysis (6 papers), Medical Imaging Techniques and Applications (5 papers) and Photosynthetic Processes and Mechanisms (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.2k citations), Epidemiology (1.3k citations), Oncology (1.0k citations), Neurology (518 citations) and Cellular and Molecular Neuroscience (194 citations). Jack L. Erion has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Marion de Jong, Eric P. Krenning, Michelle Schmidt, Willem H. Bakker, Ananth Srinivasan, Joan E.B. Fox, Dik J. Kwekkeboom, P.P.M. Kooij, A. Srinivasan and Joseph E. Bugaj. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Cancer Biotherapy and Radiopharmaceuticals, Bioconjugate Chemistry, Nuclear Medicine Communications and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.